(Eagle News)–The Department of Health has upheld the Food and Drug Administration’s revocation of the Certificate of Product Registration of dengue vaccine Dengvaxia, but noted manufacturer Sanofi Pasteur may reapply. In his decision on Aug. 19, Health Secretary Francisco Duque III said  the efficacy of Dengvaxia itself was not an issue but Sanofi’s “complete disregard of FDA regulations, which were precisely put in place by law to ensure safety.” The DOH said it found that […]